In a Netflix documentary, Bryan Johnson, a tech entrepreneur, discussed his morning routine involving various therapies, exercise, and supplements from his longevity start-up, Blueprint, aimed at achieving the lowest biological age. However, Johnson’s use of legal confidentiality agreements to control his image and silence employees has led to complaints and concerns about the company’s financial challenges and product quality issues. Former employees have raised questions about the effectiveness and safety of Blueprint’s health supplements, with some experiencing side effects, while Johnson has faced criticism for cherry-picking positive metrics from his health experiments. Additionally, Johnson’s past use of confidentiality agreements, including with his former fiancée, has sparked legal battles and public scrutiny, leading current and former employees to challenge these agreements through complaints filed with the National Labor Relations Board.
Full Article
Can investors stay optimistic about Russian stocks?
War and peace are challenging to price, but with Donald Trump seeking a ceasefire in Ukraine, investors are starting to evaluate Russian assets more positively. Despite sanctions making direct dealing difficult, Russian-linked firms in other markets are thriving. Although some see potential in deeply discounted Russian securities, the volatile geopolitical landscape and ongoing sanctions present significant risks for investors. Full Article
Read more